
Novo Partners With Anthropic on AI
Novo Nordisk has partnered with Anthropic to utilize Claude models for accelerating drug discovery and research workflows. The drugmaker aims to shorten timelines and enhance human biology research through artificial intelligence.
Xurve View
Insights:
Xurve View

NOVO NORDISK A/S-B partnered with artificial intelligence firm Anthropic on Wednesday afternoon to accelerate drug discovery and development using advanced language models. The Denmark-based pharmaceutical giant is expanding its technology deployment across research workflows. The collaboration aims to shorten R&D timelines and deepen the understanding of human biology.







